Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China flag China · Delayed Price · Currency is CNY
40.12
-1.82 (-4.34%)
Nov 17, 2026, 3:00 PM CST

SHA:688513 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,3031,3311,3501,1171,1711,023
Revenue Growth
-1.98%-1.36%20.82%-4.56%14.43%10.96%
Gross Profit
981.68995.181,005890.18971.4876.62
Operating Income
160.44198.94168.42152.2157.4135.47
Net Income
272.52284.06238.23226.57246.52232.43
Earnings Per Share
1.581.631.361.281.391.32
EPS Growth
15.16%19.85%6.25%-8.22%5.68%8.98%

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
Northeast China Region
58.86
Northern China
212.86
East China
476.68
Southern China
164.98
Central China Region
92.99
Northwestern Region
37.56
Southwest Region
253.79
Overseas Regions
31.38
Total
1,329

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,7581,6131,4241,5231,3471,505
Total Debt
204.93146.65114.04223.48105.2920.02
Net Cash (Debt)
1,5531,4671,3101,3001,2421,485
Net Cash Growth
8.41%11.99%0.78%4.63%-16.33%-6.35%
Net Cash Per Share
9.008.427.487.347.038.43

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
260.32264.94263.24275.25151.94147.6
Capital Expenditures
-90.48-86.28-117.42-175.26-339.33-270.19
Free Cash Flow
169.84178.66145.8299.99-187.38-122.59
Free Cash Flow Growth
-32.67%22.52%45.83%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
75.36%74.75%74.42%79.68%82.99%85.70%
Operating Margin
12.32%14.94%12.48%13.62%13.45%13.24%
Pretax Margin
20.30%22.51%18.71%21.63%22.38%24.14%
Profit Margin
20.92%21.34%17.65%20.28%21.06%22.72%
FCF Margin
13.04%13.42%10.80%8.95%-16.01%-11.98%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.4900.4900.4300.3950.3810.531
Dividend Per Share Growth
13.95%13.95%8.97%3.57%-28.19%159.97%
Dividend Yield
1.22%0.80%1.43%0.91%0.92%1.68%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
25.4037.7822.0533.8129.6423.97
Forward PE
25.7336.0716.2125.3322.5620.69
P/FCF Ratio
40.8460.0736.0276.60--
PS Ratio
5.328.063.896.866.245.45